InsidersTradesSigma
Track the SK바이오사이언스 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, SK바이오사이언스 has logged 2 reports. Market capitalisation: €2,698.9bn. The latest transaction was reported on 27 March 2026 (Purchase). Among the most active insiders: SK케미칼. All data is free.
2
Insider Decl.
n/a
Thresholds
€115,619
2 ops.
Buy Volume
n/a
n/a
Sell Volume
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,641 of 29,064 companies
20.1
score / 100
Value24
Quality17
FCF yld-5.8%
Earn yld-2.1%
EV/EBITDA·
ROE-4.3%
Gross mgn12%
Net mgn-8.8%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 March 2026
关于 SK바이오사이언스
SK Bioscience 是一家韩国公司，专注于疫苗和生物制剂的开发和制造。该公司在 XKRX 市场上市。